INSIST! Chronic Lymphocytic Leukemia
December 2025
Biomarker testing in Chronic Lymphocytic Leukemia (CLL) is essential to ensure patients are receiving the best, most personalized care available. The goal of INSIST! CLL is to educate and empower patients and care partners to speak up and insist on better care.
Program topics include:
Personalize Your Experience!
Create an account to save items and receive information curated just for you.
Understanding CLL Testing
Self-Advocacy | Why In-Depth Cancer Testing Is Essential
December 5, 2025
Molecular Testing and Hereditary Testing: What’s the Difference?
December 5, 2025
When Should Someone With Cancer Undergo Molecular Testing?
November 6, 2025
What Is Molecular Testing and Why Is It Necessary in Cancer Care?
November 6, 2025
What Are Common Symptoms of CLL?
May 14, 2021
CLL Treatment Decisions
How Can CLL Patients Insist on Better Care?
May 14, 2021
How Can I Tell if My CLL Treatment is Effective?
May 14, 2021
What is High-Risk CLL and How Is It Treated?
May 14, 2021
What Factors Impact CLL Treatment Options?
May 14, 2021
Which CLL Treatment is Right for You? Resource Guide
April 29, 2021
CLL INSIST! on Better Care Resource Guide
November 6, 2020
This program is supported by AbbVie, Janssen, and Pharmacyclics, and through generous donations from people like you.